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INTRODUCTION
Laryngoscopy and intubation cause a marked increase in adrenergic activity 
due to stress response.  The resulting tachycardia, hypertension and arrhythmias 
may cause hemodynamic instability in patients with cardiovascular disease.
Laparoscopic  procedures  for  both  diagnostic  and  surgical  purposes  are 
becoming increasingly popular. They offer specific advantages to the patient like, 
less  post  operative  pain35,27,  less  severe  respiratory  dysfunction  and  quicker 
recovery13,41,less tissue damage and inflammation13,10,nitrogen balance and immune 
function  are  better  preserved5,  shorter  hospital  stay,  early  ambulation,  less 
morbidity and smaller scars.  Carbon dioxide pneumoperitoneum produced during 
these procedures causes similar hemodynamic changes as in airway manipulation. 
This may be due to44,
 Increased intra abdominal pressure, 
Neurohumeral responses and 
Absorbed carbon dioxide leading to hypercarbia
A
Much of the initiation of the stress response relies on the outflow of the 
sympathetic  neuronal  pathway.   Many  pharmacological  techniques  using 
adrenoreceptor blockers, calcium channel blockers, opioids, vasodilators were used 
to attenuate these responses, which indicates lack of an  ideal drug for this purpose. 
Metoprolol, a selective β1 adrenergic blocking agent acts by,
 competitive antagonism of catecholamines at peripheral(especially cardiac) 
adrenergic neuron sites, leading to decreased blood pressure;
 Central effect leading to reduced sympathetic outflow to the periphery;
 Suppression of renin activity.
 These properties of metoprolol make it suitable for suppressing the stress 
response.   Moreover,  the  elimination  halftime  of  Metoprolol43 being  3.5  hours 
allows it to be administered as a single dose covering the duration of surgery. Thus 
in this study we are evaluating the efficacy of injection metoprolol 50 micrograms/
kg. i.v., in attenuating these stress responses.
k
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AIM OF THE STUDY
1. To  study  the  efficacy  of  Inj.Metoprolol  50  micrograms/kg  i.v. 
given  5  minutes  before  induction  of  anesthesia  in  attenuating 
hemodynamic  stress  response  to  laryngoscopy,  intubation  and 
carbon  dioxide  pneumoperitoneum  in  laparoscopic 
appendicectomies.
2. To observe for any complications related to inj.Metoprolol during 
intra operative period and 8 hours postoperatively.
ŒSYMPATHETIC RESPONSE TO LARYNGOSCOPY
Laryngoscopy and intubation produces a cardiovascular stress response.  The 
Cardiovascular changes during laryngoscopy and endotracheal intubation are 
Hypertension, 
Tachycardia and
 Dysrrhythmias.  
The body reacts to external stimuli, ranging from minor to massive insult 
both locally and generally.  The general response is in the form of wide spread 
endocrinal,  metabolic  and  biochemical  reactions  throughout  the  body.   The 
magnitude of the response is highly dependent on severity, intensity and duration 
of  the stimulus.   For triggering such reflex response and presenting a complex 
interplay  of  substances  between  the  hypothalamic  pituitary  axis,  the  classical 
neuro-endocrine  hormone  system and  autonomic  nervous  system is  brought  to 
action and is called “stress response2”
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During  laryngoscopy  and  intubation  the  mechanical  stimulation  of  upper 
respiratory tract viz nose, epipharynx, laryngopharynx, the afferents are carried by 
glossopharyngeal nerve: from tracheobronchial tree via vagus nerve which 
enhances  the  activities  of  the  cervical  sympathetic  afferent  fibres  resulting  in 
transient  rise  in  heart  rate  and  blood  pressure24.  There  is  increase  in  plasma 
epinephrine, norepinephrine and vasopressin concentrations during laryngoscopy 
and intubation14.
In healthy patients these responses are well tolerated.  However, in patients 
with limited coronary or myocardial reserve, myocardial ischemia or failure may 
follow.
Because the MAC for endotracheal intubation is about 30 percent higher 
than MAC for surgical  incision44,  a  relatively deep level  of anesthesia must  be 
established to blunt these responses.  Deeper anesthesia may not be well tolerated 
by  many  patients.   So  drugs  that  tend  to  block  the  response  to  airway 
instrumentation or antihypertensives can be used.
Opioids such as Fentanyl,  Alfentanyl and Remifentanyl are an option for 
blunting the stress response to intubation.
Lignocaine in a dose of 1.5mg/kg. intravenously is also used to blunt this 
response.   Topical  anesthesia  with  lignocaine  is  a  less  effective  method  for 
blunting  the  hemodynamic  responses  to  laryngoscopy  because  laryngoscopy 
precedes  intra  tracheal  administration of  lignocaine.   Transtracheal  injection  of 
local anaesthetic avoids laryngoscopy but it is stimulating in its own right. 
Glossopharyngeal  and  superior  laryngeal  nerve  blocks  may  also  be  effective 
methods to blunt the hemodynamic response to laryngoscopy.
A variety of antihypertensive agents have also been used to diminish the 
hemodynamic responses to intubation.  These include ß adrenergic blockers like 
esmolol,metoprolol  and  propranolol;,Phentolamine,Nitroprusside,Nitroglycerine, 
Clonidine and Hydralazine, all have their own advocates.
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 HEMODYNAMIC ALTERATIONS DUE TO CO2 
PNEUMOPERITONEUM
Hemodynamic Repercussions In Healthy Patients
Peritoneal insufflation to intra abdominal pressures higher than 12 mm of 
Hg. induces significant alterations of hemodynamics.  They are ,
Elevations of Arterial Pressure
Increase in Heart Rate
Increase in Systemic and Pulmonary Vascular Pressures 
Decrease in Cardiac Output
These adverse hemodynamic effects of pneumoperitoneum have been 
confirmed by studies using pulmonary artery catheterisation8, thoracic electrical 
bio impedance42, esophageal echo-doppler31,and tran sesophageal 
echocardiography26.
The mechanism of decrease in cardiac output  is  probably multi  factorial, 
decrease  in  venous  return  being  the  most  important.   Cardiac  filling  pressures 
however  rise  during  peritoneal  insufflations.   The  paradoxic  increase  in  these 
pressures can be explained by the increased intra thoracic pressure associated with 
pneumoperitoneum.  The reduction in venous return and cardiac output  can be 
attenuated by increasing the circulating volume before the pneumoperitoneum by 
fluid loading44.
Increase in Systemic Vascular Resistance during pneumoperitoneum cannot 
be considered simply  to  be a  reflex sympathetic  response  to  decreased  cardiac 
output.  Indeed Systemic Vascular resistance also increased in studies in which no 
decrease  in  cardiac  output  was  reported32.  The  increase  in  systemic  vascular 
resistance is considered to be mediated by mechanical as well  as neurohumoral 
factors41.  Indeed, the return of hemodynamic variables to baseline is gradual and 
takes several minutes suggesting neurohumoral factors38,41.   Catecholamines, the 
renin angiotensin system and vasopressin released during pneumoperitoneum may 
contribute  to  increasing  afterload8,42.   Mechanical  stimulation  of  peritoneal 
receptors  also  results  in  increased  vasopressin  release28,systemic  vascular 
resistance and arterial pressure21.
Urine output, renal plasma flow and glomerular filtration rate decrease to 
less than 50 percent of baseline values during laparoscopic surgeries than during 
open surgeries9.  Urine output significantly increases after desufflation.
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 Hemodynamic Repercussions Of Pneumoperitoneum In High Risk Cardiac 
Patients
In patients with mild to severe cardiac disease, the pattern of change in mean 
arterial pressure, cardiac output and systemic vascular resistance is qualitatively 
similar  to that  in healthy patients34,36.   Quantitatively these changes seem to be 
more  marked,  putting these  patients  at  increased  risk  of  developing congestive 
cardiac failure.
Cardiac Arhythmias During Laparoscopy
Arrhythmias during laparoscopy may have several causes.  Hypercapnia is 
blamed  more  often.  But,  arrhythmias  are  not  correlated  with  PaCO2 and  may 
develop during insufflation,  when high PaCO2 is  unikely.   Reflex increases in 
vagal  tone may result  from sudden stretching of  the peritoneum.  Bradycardia, 
cardiac arrhythmias and even asystole can develop.  Gas embolism can also result 
in cardiac arrhythmias44.
.
Cardiac  irregularities  most  often  occur  early  during  insufflation,  when 
pathophysiologic  hemodynamic  changes  are  most  intense20.   For  this  reason, 
arrhythmias may also reflect  intolerance of  these hemodynamic disturbances in 
patients with known or latent cardiac disease.
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1HEMODYNAMIC  ALTERATIONS  DUE  TO  POSITIONING  AND 
VENTILATORY CHANGES DURING LAPAROSCOPIC SURGERIES 
HEMODYNAMIC EFFECTS OF POSITIONING
Laparoscopic surgeries  may require steep head up or head down tilt.  Head 
down position results in  increase in central venous pressure and cardiac output. 
These changes are greater with coronary artery disease patients, especially with 
poor ventricular function, leading to potentially deleterious,  increased myocardial 
oxygen demand.  
In head up position, a decrease in cardiac output and mean arterial pressure 
is observed secondary to reduction in venous return32,8.  This decrease in cardiac 
output compounds the hemodynamic changes induced by pneumoperitoneum.
Venous stasis occurs in the leg during head up position. Pneumoperitoneum 
further increases the venous pooling in the leg.
(RESPIRATORY CHANGES DURING LAPAROSCOPIC SURGERIES
PaCO2 progressively increases to reach a plateau 15 to 30 minutes after the 
beginning of CO2 insufflation in patients under controlled mechanical ventilation 
in either trendelenberg position38 or head up position4. This hypercarbia contributes 
to  the  Heart  Rate  and  Blood  Pressure  response  during  laparoscopic  surgeries. 
Causes of increased PaCO2 during laparoscopy are
CO2 absorption from peritoneal cavity
V/Q mismatch due to abdominal distension and position of the patient
Increased metabolism
Decreased thoracopulmonary compliance6,7,33.
Depression of ventilation by anaesthetics(spontaneously breathing)
Accidental events CO2 emphysema, Capnothorax, CO2 embolism
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 Various methods and pharmacological agents are being used to overcome 
the adverse hemodynamic effects of the pneumoperitoneum. Some of them are,
Preoperative preload augmentation to offset the reduced venous return and cardiac 
output.
Vasodilators like Nitroglycerin to correct the reduction in cardiac output associated 
with increased pulmonary capillary occlusion pressures and systemic vascular 
resistance.
Calcium channel blockers like Nicardipine acts selectively on arterial resistance 
vessels and reduces systemic vascular resistance without compromising venous 
return34.
ß adrenergic blockers
α2 adrenergic agonists such as clonidine or dexmedetomidine significantly reduce 
both hemodynamic changes and anaesthetic requirements1.
.
ADRENERGIC RESPONSES MEDIATED THROUGH 
αAND ß RECEPTORS
S.No α actions ß actions
1. Constriction  of  arterioles  and 
veins→increase in BP(mainly α 1)
Dilatation  of  arterioles  and  veins→fall 
in BP(ß2)
2. Heart-little  action,arrhythmias  at 
high dose(α1)
Cardiac  stimulation(ß1),increased 
rate,force and conduction velocity
3. - Bronchodilatation(ß2)
4. Contraction  of  radial  muscles  of 
iris→mydriasis(α1)decreased 
aqueous secretion
No effect on iris and ciliary muscle.
Enhanced aqueous secretion
5. Intestinal relaxation, Contraction of 
sphincters.
Intestinal relaxation(ß2)
6. Bladder trigone-contraction Detrusor-relaxation
7. Splenic capsule contraction Relaxation(slight)(ß2)
8. Uterus-contraction Relaxation(ß2)
9. Neuro  muscular  transmission 
facilitated,Increased Ach. Release
Active  state-prolonged  in  fast 
contracting  muscle.abbreviated  in  slow 
contracting muscle;tremors(ß2)
10. Insulin  secretion 
inhibited(dominant)(α2)
Augmented insulin(mild)  and glucogon 
secretion(ß2) 
11. Liver-glycogenolysis(α  in  some 
species)
Liver-glycogenolysis(ß2) 
→hyperglycemia
Muscle-
glycogenolysis,ß2→hyperlactacidemia
Fat-lipolysis(ß3)  →increased  blood 
FFA,calorigenesis.
12. - Renin release from kidney(ß1)
13. Salivary gland-pottasium and water 
secretion(α1)
Ptylin secretion
14. - ADH secretion from posterior pituitaryß 
1)
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 Among the ß receptors ß1 receptors are located in heart and JuxtaGlomerular 
cells  in  kidney;  ß2 receptors  are  located  in  bronchi,blood 
vessels,uterus,gastrointestinal  tract  and eye;  ß3 receptors  are  located  in  adipose 
tissue.
 PHARMACOLOGY OF METOPROLOL
Metoprolol tartrate , is a selective ß1-adrenoreceptor blocking agent, 
available as 50- and 100-mg tablets for oral administration and in 5-mL ampoules 
for intravenous administration. Each ampoule contains a sterile solution of 
metoprolol tartrate , 5 mg, and sodium chloride , 45 mg, and water for injection. 
Metoprolol tartrate  is (±)-1-(Isopropylamino)-3-
[ p(2methoxyethyl)phenoxy]-2-propanol L-(+)- tartrate (2:1) salt is and its 
structural formula is
 Physical properties
Metoprolol has a very low melting point. Its melting point is around 45 degrees 
Celsius (as determined by Differential scanning calorimetry). For this reason 
metoprolol is always manufactured in salt form, as drugs with melting points 
below 100 degrees Celsius are difficult to work with in a manufacturing 
environment. The free base exists as a waxy white solid, where the tartrate salt is 
finer crystalline material
f
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MECHANISM OF ACTION
 Metoprolol’s mechanism of action :
1)  competitive  antagonism  of  catecholamines  at  peripheral (especially 
cardiac) adrenergic neuron sites, leading to decrease in blood pressure; 
(2) a central effect leading to reducd sympathetic outflow to the periphery; 
and 
(3) suppression of renin activity
 
PHARMACO DYNAMICS
• Cardioselective 
• Moderately Lipophilic 
• Without intrinsic sympathomimetic activity (ISA) 
• With weak membrane stabilizing activity 
• Short  half-life (t1/2 is  3.5 hours.),  therefore must  be taken at  least  twice 
daily or as a single dose Slow-release preparation. 
• Decreases  Heart  Rate,  Contractility  and  Cardiac  Output,  therefore 
decreasing blood pressure.
•
•
• Metoprolol  reduces  or  inhibits  the  agonistic  effects  on  the  heart  of 
catecholamines(which are released during periods of physical or mental 
stress).  This means that the usual increase in heart rate, contractility 
and blood pressure, produced by acute increases in catecholamines is 
decreased by metoprolol.
• When  given  together  with  a  ß2 agonist,  metoprolol  in  therapeutic  doses 
interferes  less  than  nonselective  ß  blockers  with  the  ß2 mediated 
bronchodilatation produced by the ß2 agonist. When mandatorily required it 
can be given to patients with obstructive pulmonary disease along with a ß2 
agonist.
• Metoprolol interferes less with insulin release and carbohydrate metabolism 
than do non selective ß blockers.
• Interferes much less with cardiovascular response to hypoglycemia than do 
non selective ß blockers.
• Metoprolol may cause a slight increase in triglycerides, decrease in free fatty 
acids, small decrease in the High Density Lipoproteins.
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 PHARMACO KINETICS
Absorption and Distribution
After  i.v.  injection,  metoprolol  is  rapidly  distributed  in  the  initial 
5minutes to 10 minutes.After oral administration completely absorbed.  Peak 
plasma concentrations obtained after 1.5 to 2 hours.  Owing to extensive 
first-pass effect,  bio availability of metoprolol after oral dose is 50 to 70 
percent.  The plasma protein binding of metoprolol is low, 5 to 10 percent.
Metabolism and Elimination43
Metoprolol undergoes oxidative metabolism in the liver.  Three main 
metabolites have been identified, none of them have a ß blocking effect of 
clinical importance. Elimination half life of metoprolol in plasma averages 
3.5 hours(extremes:1 and 9 hours).  The total clearance rate is approximately 
1 litre/minute.
Elderly  show  no  significant  changes  in  the  pharmacokinetics  of 
metoprolol as compared to the young adults.The systemic bio availability 
and elimination of metoprolol is unchanged in persons with reduced renal 
function.Due to its low protein binding the pharmacokinetics of metoprolol 
is  little  affected  by  decreased  liver  function.   However,  in  patients  with 
severe cirrhosis and portacaval shunt the bio availability of metoprolol may 
increase and the total clearance may be reduced.
INDICATIONS
Usual indications of metoprolol are:
Disturbances of cardiac rhythm especially supraventricular tachycardia.
Suspected or confirmed myocardial infarction.
Angina pectoris
Hypertension
Dosage and Method of Administration of I.V. Metoprolol
Initially upto 5mg injected intravenously at a rate of 1 to 2 mg per minute. 
The injection can be repeated at 5 minute intervals until a satisfactory response has 
been obtained.  A total dose of 10 to 15mg generally proves sufficient.  Doses of 
20mg or more are unlikely to result in further therapeutic benefit.
Second  or  third  dose  should  not  be  given  if  the  heart  rate  is  less  than 
40/minute,or if the systolic BP is less than 90 mm of Hg., or the P-Q time is more 
than 0.26 seconds.
Dose  adjustments  are  not  needed  in  elderly  or  persons  with  renal 
impairment.  Dose adjustments is usually not needed in liver cirrhosis. But when 
there are signs of serious impairment of liver function or shunt operated patients a 
dosage reduction should be considered.
d
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In Pregnancy and Lactation
Metoprolol should not be given in pregnancy and lactation unless its use is 
considered  essential.  May  cause  bradycardia  in  fetus,  newborn  and  breast  fed 
infant.  However the amount of metoprolol ingested through breast milk seems 
negligible to produce significant clinical effects.
CONTRAINDICATIONS
Metoprolol is contraindicated in sinus bradycardia, heart block greater than 
first  degree,  significant  first-degree  heart  block  (P-R  interval  =0.24  sec), 
cardiogenic shock, and overt cardiac failure .
Hypersensitivity  to  Metoprolol  and  related  derivatives,  or  to  any  of  the 
excipients;  hypersensitivity  to  other  ß-blockers  (cross  sensitivity between  ß-
blockers can occur).
Sick-sinus  syndrome.
Severe  peripheral arterial circulatory disorders.
Pheochromocytoma : Should not be given without α blockade
 SPECIAL WARNINGS INTERACTION AND PRECAUTIONS
Intravenous administration of calcium antagonists should be used with caution in 
patients treated with ß blockers.
Patient receiving concomitant treatment with sympathetic ganglion blocking 
agents, other ß blockers(i.e.eye drops),or Monamine Oxidase Inhibitors should be 
kept under close surveillance.
Enzyme inducing and enzyme inhibiting drugs affect the plasma concentration of 
metoprolol. Plasma concentration of metoprolol is lowered by rifampicin and may 
be raised by cimetedine, alcohol and hydralazine.
Concomitant treatment with Indomethacin or other prostaglandin synthatase 
inhibiting drugs may decrease the antihypertensive effect of metoprolol.
In patients with Asthma concomitant treatment with ß2 agonist should be started.
In patients suffering from cardiac failure should have their decompensation treated 
both before and during treatment with metoprolol.  If the patient develops 
increasing bradycardia metoprolol should be given in lower doses or gradually 
withdrawn.
Abrupt interruption of the medication to be avoided.
A
Metoprolol may aggravate the symptoms of peripheral arterial circulatory 
disorders.
In pheochromocytoma an α blocker should be given concomitantly.
Prior to surgery anesthetist should be informed about the metoprolol treatment.  It 
is not recommended to stop ß blockers in patients undergoing surgery.  Inhalational 
anesthetics enhance the cardiodepressants effect of ß blockers.
a
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SIDE EFFECTS OF METOPROLOL.
Metoprolol is well tolerated and adverse reactions have generally been mild 
and reversible.   The  following events  have  been reported  as  adverse  events  in 
clinical trials or from routine use.  In many cases a relationship to treatment with 
metoprolol has not been established.
Sys-tem
V.common
More than 10% 
Common
1-9.9%
Uncommon
0.1-0.9%
Rare
0.01-o.09%
Very rare
Less than 0.01%
CVS
Bradycardia,
postural disorders,cold extremities,palpitations
Transient detoriation of heart failure,first degree block,oedema,pericardial pain
Arrhythmias,conduction disturbances
Gangrene in patients with peripheral vascular disease.
RS
Dyspnea on exertion
Bronchospasm
Rhinitis
CNS
Fatigue
Dizziness,headache
Parasthesia,muscle cramps
GIT
Nausea,abdominal pain,diarhea,
Constipation
Vomiting
Dry mouth,LFT abnormalities
Hepatitis
Thrombocytopenia, arthralgia, weight gain, depression, impaired 
concentration, sleep disturbances, nightmares, anxiety, sexual dysfunction, 
confusion, skin rash, loss of hair, photosensitivity, aggravation of psoriasis, 
conjunctivitis, tinnitus, taste disturbances can also occur during Metoprolol 
treatment.
t
Several cases of overdosage have been reported, some leading to death.
Potential  signs and symptoms associated with over  dosage with metoprolol  are 
bradycardia, hypotension, bronchospasm, and cardiac failure.
Treatment of Metoprolol overdose47
There is no specific antidote.On the basis of pharmacologic actions of 
Metoprolol, the following general measures should be employed
Bradycardia: Atropine should be administered. If there is no response to 
vagal blockade, isoproterenol should be administered cautiously.
Hypotension: A vasopressor should be administered, e.g., norepinephrine or 
dopamine.
Bronchospasm: A ß 2-stimulating agent and/or a theophylline derivative 
should be administered.
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Cardiac Failure: A digitalis glycoside and diuretic should be administered. 
In shock resulting from inadequate cardiac contractility, administration of 
dobutamine, isoproterenol should be considered.
Glucagon in a dose of 1 to 10mg can be administered.
Pacemaker may be necessary.
Note: Dosage of drugs needed to treat overdose of ß blockade are much 
higher than the normally recommended therapeutic doses.  This is because ß 
receptors are occupied by the ß blockers
r
REVIEW OF LITERATURE
In 1970 , A. Millar Forbes,M.B.,C.H.B.,F.F.A.R.C.S, and F.G.Dally 
M.B.B.S..M.R.A.C.G.P et al30  studied  twenty two normotensive patients , 
anesthesia was induced with thiopentone and suxamethonium. They found that 
laryngoscopy and endotracheal intubation were immediately followed by an 
average increase in Mean arterial pressure of 25mm of Hg. 
In 1977, Lammintausta R, Syvalahti E et al19, studied the effect of ß blockers 
propranolol and metoprolol on haemodynamics and plasma rennin activity of 
healthy volunteers in an ergometric exercise test.  Oral doses of 160mg of 
propranolol and 200 mg of metoprolol were tested against placebo.  Propranolol, 
but not Metoprolol decreased the basal level of Plasma rennin activity.  Exercise 
induced significant increase in plasma rennin activity in placebo group, but this 
increase was partially inhibited by both the drugs.  On the basis of these findings it 
is suggested that in man the basal level of plasma rennin activity could be 
decreased mainly by blocking the ß 2 adrenoreceptors.  Instead exercise induced 
increase of plasma rennin activity could be inhibited by blocking the ß-1 
adrenergic receptors.
T 
In 1978, Stoelting R.K., et al40, studied the changes in Mean Arterial Pressure and 
Heart Rate during short duration(less than 15 seconds) laryngoscopy and tracheal 
intubation in 24 patients undergoing elective coronary artery bypass grafting. He 
concluded that, laryngotracheal lidocaine administration just before tracheal 
intubation minimizes pressor response to intubation.
In 1986, J. Magnusson,T. Thulin, O.Werner et al22.,studies the hemodynamic effect 
of pretreatment with metoprolol in  patients undergoing surgery under general 
anesthesia with thiopentone-fentanyl-nitrous oxide-pancuronium. Patients were 
divided into two groups of 15. One group received metoprolol tablets 200mg in a 
slow release form, once daily for at least 2 weeks including the morning of 
surgery.  In addition , metoprolol 15mg was injected i.v. shortly before induction 
of anesthesia.  The other group received placebo tablets and saline. They 
concluded that metoprolol significantly reduced arterial pressure both during 
undisturbed anesthesia and during intubation and after extubation.
In 1991, K. Samchung M.D. of yale university, NewHayen37  conducted a 
randomized double blind study to compare a combination of esmolol and fentanyl 
with that of either agent alone in blunting the hemodynamic 
response to intubation. They compared fentanyl 2 mic.gms./kg., esmolol 
2mgm./kg., fentanyl 2mic.gms./kg with esmolol 2mgm./kg and fentanyl 5 
mic.gms./kg. in blunting the hemodynamic response to intubation. The study 
concluded that combination of esmolol 2mgm/kg. with fentanyl 2 mic./kg. is better 
than either of them alone.
In 1992, Mikawa K, Hasegawa M, Suzuki T, Obara H et al29 of Japan evaluated the 
efficacy and safety of intravenous (IV) nitroglycerin in attenuating the 
hypertensive response to laryngoscopy and intubation in a controlled, randomized, 
double-blind study. Thirty normotensive patients (ASA physical status I) 
undergoing elective surgery were divided into three groups of ten patients each. 
Anesthesia was induced with thiopental sodium 5 mg/kg i.v., and tracheal 
intubation was facilitated with vecuronium 0.2 mg/kg i.v. During anesthesia, 
ventilation was assisted or controlled with 1% enflurane and 50% nitrous oxide in 
oxygen. Either 1.5 micrograms/kg of nitroglycerin, 2.5 micrograms/kg of 
nitroglycerin, or saline (control) was administered IV simultaneously with the start 
of laryngoscopy (lasting 30 seconds), which was attempted 2 minutes after 
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administration of thiopental sodium and vecuronium. Patients receiving saline 
showed a significant increase in mean arterial pressure and rate-
pressure product associated with tracheal intubation. These increases following 
tracheal intubation were significantly reduced in nitroglycerin-treated patients 
compared with those in the control group 
In 1995. Kumar M., Tikkle AC17  conducted a study in 60 randomly selected 
normotensive patients(ASA I and II) of age 20 years and above.  Patients were 
divided into two groups of 30 each.  Group 1 was the control group and received 
normal saline as placebo 5 minutes before induction; group 2 patients received i.v. 
Metoprolol 3 mg. 5 minutes before induction of anaesthesia.  All patients were 
anaesthetized by thiopentone and pancuronium and intubated.  It was observed that 
Metoprolol given 5 minutes before induction of anaesthesia effectively attenuated 
the cardiovascular response to laryngoscopy and endotracheal intubation to 
clinically significant levels.
In 1997 Walder AD, Aitkenhead AR et al42, in a study of patients undergoing 
laparoscopic cholecystectomy measured heart rate, arterial pressure, right atrial 
pressure, cardiac index, catecholamines and vasopressin, and noticed increase in 
plasma vasopressin concentration after insufflations of the pneumoperitoneum to a 
level sufficient to cause the recorded haemodynamic changes(increase in arterial 
pressure, systemic vascular resistance). 
p
In 1998 Koivusalo AM, Schejnin M and Tikkanen I of Finland16 studied the effect 
of esmolol on CO2 pneumoperitoneum induced hemodynamic changes in 
laparoscopic surgeries. In this double blind randomized study esmolol was 
compared with isotonic saline in 28 patients undergoing laparoscopic surgery in 
standardized 1 MAC Isoflurane anaesthesia.   Alfentanil infusion was used to 
prevent the increase in Mean Arterial Pressure more than 25% from baseline. They 
concluded esmolol blunts the pressor response to induction and maintenance of 
pneumoperitoneum and protect against renal ischemia during pneumoperitoneum.
In 2000, J.L.Joris, J.D. Chiche J L Canivet of Belgium12 investigated endocrine 
correlates of the haemodynamic changes induced by the carbon dioxide 
pneumoperitoneum and the effect of clonidine in modifying these changes. They 
conducted two studies, each including 20 healthy patients undergoing elective 
laparoscopic cholecystectomy.  In the first study serial measurements of 
haemodynamics and plasma concentrations of cortisol, catecholamines, 
vasopressin, rennin, and endothelin were measured at the same time points. In the 
second study patients were randomly allocated to receive 8 mic./kg. clonidine 
infused over 1 hour or placebo before pneumoperitoneum.  Haemodynamics and 
the above 
hormones measured similarly.From the observations it was concluded, Vasopressin 
and catecholamines probably mediate the increase in systemic vascular resistance 
observed during pneumoperitoneum.  Clonidine given before pneumoperitoneum 
significantly reduced mean arterial pressure, heart rate and the increase in systemic 
vascular resistance.  Clonidine also reduced catecholamine concentrations 
significantly but did not alter vasopressin and cortisol plasma concentrations. 
In 2001 Margarita Coloma, JenW.chiu et al25, compared esmolol and remifentanyl 
infusions with respect to their effect on hemodynamic stability and early recovery 
after outpatient laparoscopic surgery, and concluded that provide haemodynamic 
stability during desflurane based anesthesia for outpatient gynecological 
laparoscopic surgery. 
In 2002 Dr.Arti Rathore and Dr.H.k.Gupta3, ,  studied three doses of esmolol 
50mgs, 100mgm, 150mgm in blunting Heart Rate and Blood Pressure response to 
laryngoscopy and intubation in 100 ASA I Patients undergoing elective surgery 
under general anaesthesia. They found in their study that all three doses of esmolol 
effective in blunting heart rate response to intubation, but  only 150 mgm esmolol 
was effective in attenuating the Blood Pressure response to laryngoscopy and 
intubation.
 In2005, Z.Kayhan,D,Aldemir, H.Mutlu and E.Ogus et al14 have investigated the 
concentrations of epinephrine, nor epinephrine, vasopressin and angiotensin 
converting enzyme activity to explore the role of these mediators in the neuro 
endocrine response to laryngoscopy and tracheal intubation. They studies 100 ASA 
I patients undergoing elctive surgery. Plasma epinephrine, nor epinephrine, 
vasopressin and angiotensin converting enzyme concentrations were measured at 
various time intervals and Blood Pressure and Heart Rate were recorded at 
corresponding times.  They concluded that Blood Pressure, Heart Rate, Plasma 
Epinephrine, norepinephrine and vasopressin concentrations increased in response 
to laryngoscopy and intubation, with no change in angiotensin converting enzyme 
activity in normotensive patients.
In 2005, Maharajan SK et al23, studied the effect of propranolol on hemodynamic 
response to airway manipulation and carbon dioxide pneumoperitoneum on 
patients undergoing laparoscopic cholecystectomy.  Sixty three patients 
undergoing laparoscopic cholecystectomy of ASA physical status I and II were 
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selected for the study. All patients were premedicated with diazepam 5mg, 
ranitidine 
150mg and metaclopramide 10mg in the night before surgery.  They were 
randomly divided into three groups and were given 1mg propranolol or 0.5mg 
propranolol or 1 ml of saline.  General anesthesia with pethidine, thiopentone, 
succinylcholine and endotracheal intubation and anesthesia maintained with 
oxygen, pancuronium and 1+/-0.5% halothane. Heart rate and Blood pressure were 
recorded at various intervals and recorded.  The results were statistically analysed 
and concluded that 1 mg propranolol is superior to 0.5mg in decreasing 
haemodynamic response to carbon dioxide pneumoperitoneum in laparoscopic 
surgeries in ASA I and II patients without significant bradycardia in postoperative 
period.
p
MATERIALS  AND  METHODS
After  obtaining  hospital  ethical  committee  approval  60  consenting  ASA 
Class 1 patients , with airway Mallampatti classification 1& 2, in the age group of 
15 to 45 undergoing laparoscopic appendicectomy were selected for the study.
Study design; prospective randomized double blind controlled study.
  Randomization done using a set of computer generated random numbers. The 
anaesthesia provider and the observer were blinded.  Another person other than the 
anesthesia provider and the observer loaded either inj. Metoprolol or normal saline 
as per the random numbers and gave it to the anesthesia provider. The syringes 
were labeled only with the serial no. assigned to the patient
Preoperative Assessment:
Thorough pre operative assessment with
medical history,
physical examination and
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Pinvestigations carried out in all these 60 patients
Hb%, 
Total count, differential count
Renal function tests
Blood glucose
Blood grouping
Bleeding time and Clotting time
ECG
Chest X ray.
Exclusion Criteria:
1. Hypertension
2. Ischemic heart disease
3. Diabetes mellitus
4. COPD, Bronchial Asthma
5. ECG: rhythm other than sinus, any degree of heart block
6. more than 1 attempt at intubation
7. peripheral vascular disease 
8. Patients  who were converted to  open surgery  after  laparoscopic 
visualisation
   All the 60 patients were given Tablet Alprazolam 0.25mg, Cap.Omeprazole 
20mg, Tablet Ondoncetron  4 mg  night before surgery.
On the morning of surgery, while the patient was at rest in the ward Heart 
Rate and Blood Pressure recorded and these were taken as basal values for the 
patient.
Premedication:  For all the patients Inj.glycopyrolate 0.2mg i.m.given 1 hr before 
surgery.   
Monitors
In the operation theatre, patients will be connected to       
I
ECG monitor
 Non Invasive Blood Pressure Monitor
 Pulse oxymeter and
 End tidal carbon dioxide
Urine Output were monitored , and all base line values recorded.
In the OT, intravenous access will be established.  All the patients will be 
given a crystalloid fluid bolus of 10 ml/kg. to compensate for overnight starvation 
and  prevent  hypotension  produced  by  decreased  venous  return  during 
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pneumoperitoneum  Then  maintenance  crystaloid   fluid  will  be  started  at 
2ml/kg/hour 
Five minutes before induction of anesthesia, the contents of the syringe
( either inj.Metoprolol 50mic.gm/kg diluted to 10 ml or 10ml normal saline) given 
intravenously over a period of 3 minutes,
 ANESTHESIA
 All the 60 patients  received  inj.fentanyl 2 micrograms/kg for analgesia and 
additional 0.5 micrograms /kg every hour for the duration of surgery.  They were 
induced with inj.Propofol 2mg/kg. and inj. Succinylcholine 1.5mg/kg for muscle 
relaxation,  and  intubated  60seconds  after  succinylcholine  injection  with  an 
appropriate size cuffed endotracheal tube.  Intubation was done by the same person 
in all the cases. Bilateral equal air entry was confirmed. Anesthesia was maintained 
 
with  nitrous  oxide  oxygen  mixture  4/2  litres,  with  isoflurane  1  MAC  and 
Inj.Vecuronium for muscle relaxation.
ET  CO2  maintained  between  25  to  35  mm  of  Hg  by  adjusting  the  minute 
ventilation
 
Intra abdominal pressure maintained at 12 mm of Hg by CO2 insuffolation. 
Inj.Neostigmine  and  inj.glycopyrolate  were  used  for  reversal  of  muscle 
relaxation.  Heart  Rate,  SpO2,  ETCO2   monitored  continuously  and  Blood 
Pressure(systolic,diastolic,MAP)   recorded  every  5  minutes,  before  intubation, 
one ,five minutes after intubation, before extubation and after extubation and as 
often required.
o
Measurements taken at the following timings were noted.
 1. Basal
2. One, five minutes after Intubation
3. Before pneumoperitoneum
4. At 15 minutes  intervals after establishing pneumoperitoneum
5. Before Extubation and after Extubation
In addition the following things were noted.
1. Duration of the Laryngoscopy
2. Duration of Pneumoperitoneum
3. Episodes  of  hypertension.,  were  managed  with  additional  inj.Fentanyl 
0.25microgram/kg.and the total dose of fentanyl required noted down. If 
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hypertension persisted, after ruling out hypercarbia it was managed with 
increasing the isoflurane concentration, and this was noted down.
4. Episodes of hypotension managed by fluid boluses and vasopressors .
5. Hourly Urine output 
6. ECG Changes, any Arrhythmias, Bradycardia, whether associated with 
hypotension
7. Bronchospasm
8.  Any  other  complications,  Patients  were  monitored  for  8  hrs  post 
operatively for observation of any side effects.
o
For the purpose of the study the following definitions were made.
1.Hypertension: increase in MAP more than 25% 0f basal values
2.Hypotension: decrease in MAP more than 25% of basal values
3.Bradycardia: decrease in heart to less than 60/minute.
At the end of the study, using the random numbers chart and the patients 
serial number, patients were divided into two groups. Patients who received i.v. 
Metoprolol  were  put  in  Metoprolol  group  (Group  M).  Patients  who  received 
normal saline were put in Control group(Group C).  
OBSERVATIONS AND RESULTS
Metoprolol group(group M) and Control Group(group C) were compared in 
respect to age , sex, weight, Airway Class, Duration of laryngoscopy, Duration of 
Pneumoperitoneum and urine output.
There were no episodes of hypoxia in any patient. We were able to maintain 
EtCO2 within the 25 to 35mm of Hg. Range, in all the patients by adjusting the 
minute ventilation.
Heart Rate(HR) and Mean Arterial Pressure(MAP) values recorded at one and five 
minutes after intubation were compared with the basal values of the patient in both 
the  groups.  HR  and  MAP  recorded  15  minutes  after  establishing 
pneumoperitoneum  were  compared  with  Baseline  and  prepneumoperitoneum 
values  in  both  the  groups.  HR  and  MAP  recorded  at  15,30,45  minutes  after 
pneumoperitoneum were compared among themselves in both the groups.
In  addition  Heart  rate  and  Mean  Arterial  Pressure  values  recorded  after 
extubation were compared with pre extubation values.
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The following tests were used for statistical analysis.
1. Two Sample ‘t’ test
2. Mann-Whitney U or Wilcoxon Rank-Sum test for difference in Medians
3. One way analysis of variance(Oneway ANOWA)
P value of less than 0.05 is taken as significant.
DEMOGRAPHIC PROFILE
Age(Years)
Group Mean Standard 
Deviation
Standard Error P  value  and 
Significance
Group M 33.36 8.77 1.60 0.940
Not 
Significant
Group C 33.20 8.56 1-56
1
Mean age of the patients in Metoprolol group was 33.36 years, and 33.20 
years in Control group. There was no significant difference in age between the two 
groups.
Sex
Group Male Female
Group M 12 18
Group C 13 17
Females were more in both the groups
Females were more in  both the groups
F
Weigh(in kilograms)
Group Mean Standard 
deviation
Standard error P
Significance
Group M 57.76667 9.37 1.71 0.920
Not 
Significant
Group C 57.53 8.72 1.59
 
The Mean weight of the Metoprolol group patients was 57.76 kg, and mean weight 
of the  Control group patients was57.53 kg.There was no significant difference in 
weight between the groups.
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ÀAirway
Group MPC 1 MPC2
Group M 21 9
Group C 22 8
MPC= Mallampatti Classification
In Metoprolol group 21 patients belong to Mallampatti Airway Class I and  9 
belong to Class II. In Control group 22 patients belong to Class I and 8 belong to 
class II.
Duration of Laryngoscopy (in seconds)
Group Mean Standard 
deviation
Standard error P
Significance
Group M 15.06 2.016 0.36 0.703
Not 
Significant
Group C 15.26 2.033 0.37
 There was no significant difference in duration of laryngoscopy between the 
two groups.
Duration of pneumoperitoneum(in minutes)
Group Mean Standard 
deviation
Standard error P
Significance
Group M 84.26 18.91 3.45 0.934
Not 
Significant
Group C 83.86 18.57 3.39
There was no significant difference in the duration of pneumoperitoneum 
between the two groups
b
Urine Output at 1 hour after induction(in milliliters)
Group Mean Standard 
deviation
Standard error P
Significance
Group M 110.33 12.99 2.37 <0.01
SignificantGroup C 90.83 9.74 1.77
.
The Mean Urine Output at 1 hour after induction of anaesthesia was110.33 
ml in Metoprolol group and 90.83 ml in Control group. There was significantly 
more urine output in the Metoprolol group than the control group at 1 hour after 
induction of anesthesia.
During the 8 hour post operative period The Mean Per hour Urine Output in 
the Metoprolol group was108.5ml/hour, in the control group it was 105 ml. All the 
patients in both the groups had more than 0.5ml/kg. urine output during the post 
operative period.
o
Heart rate and Blood Pressure response to intubation 1 and 5 minutes after 
intubation compared with baseline Heart rate in both groups.
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Group M
Time Mean Standard 
deviation
Standard 
error
P
Significance
Basal HR 81.5 7.65 1.39
HR  1 minuteafter
Intubation
81.16 7.87 1.43 0.86
Not Significant
HR  5  Minutes  after 
intubation
81.46 7.04 1.28 0.98
Not significant
Basal MAP 93.96 2.76 0.50
MAP  1  minute  after 
intubation
91.46 3.98 0.72 0.006
Significant 
decrease
MAP   5  minutes  after 
intubation
91.96 4.99 0.91 0.06
Not Significant
Group C
Time Mean Standard 
deviation
Standard error P
Significance
Basal HR 82.83 8.62 1.57
HR  1 minuteafter
Intubation
86.13 9.51 1.73 0.16
Not significant
HR  5  Minutes 
after intubation
85.93 8.37 1.52 0.16
Not significant
Basal MAP 93.76 3.18 0.58
MAP  1  minute 
after  intubation
98.46 7.31 1.33 0.018
Significant
MAP   5  minutes 
after intubation
99.76 7.99 1.45 0.018
Significant
S
Heart rate and Blood Pressure response to intubation
Group M
1min= 1 minute after intubation         5 min.=5 minutes after intubation
HR=Heart Rate         MAP= Mean Arterial Pressure
In the Metoprolol group there was no significant difference in Heart 
rate from base line in both I minute and 5 minutes after intubation. There was no 
significant  difference in  MAP 5 minutes after  intubation  from baseline MAP. 
There was a small but significant decrease in MAP 1 minute after intubation  from 
baseline Mean Arterial Pressure.
b
Heart rate and Blood Pressure response to intubation
Group C
1min= 1 minute after intubation         5 min.=5 minutes after intubation
HR=Heart Rate         MAP= Mean Arterial Pressure
In the control group, there was no significant increase in Heart rate from 
Basal Heart rate in both one and five minutes after intubation. But there was a 
significant  increase  in  Mean  Arterial  Pressure  from  Basal  values  during  both 
1minute and 5 minutes after intubation.
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¨Heart  Rate  and  Mean  Arterial  Pressure  readings  measured  at  15 
minutes after establishing pneumoperitoneum were compared with basal and 
prepneumoperitoneum readings in  both the groups.
Group M
Time Mean Standard 
deviation
Standard error P
Significance
Basal HR 81.5 7.65 1.39 0.86
Not 
Significant
HR  15  minutes 
after PNP
81.83 7.26 1-32
Basal MAP 93.96 2.76 0.50 0.88
Not 
Significant
MAP 15 minutes 
after PNP
94.2 8.43 1.54
HR Before PNP 80.23 6.81 1.24 0.38
Not 
Significant
HR  15  Minutes 
after PNP
81.83 7.26 1.32
MAP  Before 
PNP
93.06 5.63 1.02 0.54
Not 
SignificantMAP 15 minutes 
after PNP
94.2 8.43 1.54
HR=Heart Rate MAP=Mean Arterial Pressure
PNP=Pneumoperitoneum
P
HR and BP response to Pneumoperitoneum:
Group M
HR=Heart Rate MAP=Mean Arterial Pressure
15 min.=15 minutes after pneumoperitoneum(PNP)
Group C
Time Mean Standard 
deviation
Standard error P
Significance
Basal HR 82.83 8.62 1.57 0.02
SignificantHR  15  minutes 
after PNP
88.53 10.79 1.97
Basal MAP 93.76 3.18 0.58 <0.01
SignificantMAP  15 
minutes  after 
PNP
104.63 13.75 2.51
HR Before PNP 77.9 6.65 1.21 <0.01
SignificantHR  15  Minutes 
after PNP
88.53 10.79 1.97
MAP  Before 
PNP
91.03 4.77 0.87 <0.01
Significant
MAP  15 
minutes  after 
PNP
104.63 13.75 2.51
HR=Heart Rate MAP=Mean Arterial Pressure PNP=Pneumoperitoneum
P
HR and BP response to Pneumoperitoneum:
Group C
HR=Heart Rate MAP=Mean Arterial Pressure
Before=Before establishing pneumoperitoneum
51
15min.=15minutes after establishing pneumoperitoneum
15 minutes after establishing pneumoperitoneum,In Metoprolol group there 
was no significant increase in Heart Rate and Mean arterial Pressure either from 
Basal or Pre Pneumoperitoneum recordings.  In Control group there was
significant increase in both Heart rate and Mean Arterial Pressure from Basal and 
Pre Pneumoperitoneum recordings.
P
Heart Rate and Mean Arterial Pressure recorded at 15,30,45 minutes 
after establishing pneumoperitoneum were compared among themselves for any 
significant increase or decrease in both the groups.
GroupM
Variable Time Mean Standard 
deviation
Standard errorP
Significance
Heart 
Rate
15  min.after 
PNP
81.83 7.26 1.32 0.858
Not 
Significant30  min.after 
PNP
82.63 7.28 1.33
45  min.after 
PNP
82.83 7.59 1.38
Mean 
Arterial 
Pressure
15  min.after 
PNP
94.20 8.43 1.54 0.98
Not 
Significant30 
min.afterPNP
94.03 3.90 0.71
45 
min.afterPNP
94.33 3.76 0.68
Group C
Variable Time Mean Standard 
deviation
Standard errorP
Significance
Heart 
Rate
15  min.after 
PNP
88.53 10.79 1.97 0.86
Not 
Significant30  min.after 
PNP
87.4 8.99 1.64
45  min.after 
PNP
88.6 8.70 1.58
Mean 
Arterial 
Pressure
15  min.after 
PNP
104.63 13.75 2.51 0.571
Not 
Significant30 
min.afterPNP
103.03 10.17 1.85
45 
min.afterPNP
101.66 7.70 1.40
HR=Heart Rate PNP=Pneumoperitoneum
MAP=Mean Arterial Pressure PNP=Pneumoperitoneum
There  was  no  significant  difference  in  the  Heart  Rate  and  Mean 
Arterial  Pressure  between  the  recordings  taken  after  15,30,45  minutes  after 
establishing pneumoperitoneum in both the groups.
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Heart  Rate  and  Mean  Arterial  Pressure  after  extubation  were 
compared with pre extubation measurements in both the groups
Group M.
Group Time Mean Standard 
deviation
Standard errorP
Significance
GroupM Before 
Extubation HR
83.73 6.84 1.25 0.30
Not 
SignificantAfter 
ExtubationHR
85.86 9.03 1.64
Before 
Extubation 
MAP
95.16 3.59 0.65 0.10
Not 
Significant
After 
Extubation 
MAP
96.76 3.97 0.72
BE=Before Extubation AE=After Extubation
HR=Heart Rate MAP=Mean Arterial Pressure
M
Group C
Group Time Mean Standard Standard errorP
deviation Significance
Group C Before 
Extubation HR
86.33 6.79 1.24 <0.01
Significant
After 
ExtubationHR
96.73 9.93 1.81
Before 
Extubation 
MAP
100.83 6.67 1.21 <0.01
Significant
After 
Extubation 
MAP
108.96 8.93 1.63
BE=Before Extubation AE=After Extubation HR=Heart Rate
MAP=Mean Arterial Pressure
In Metoprolol group, there was no significant difference in Heart Rate and 
Mean  Arterial  Pressure  between  before  extubation  and  after  extubation 
measurements.  In Control group there was significant increase in Heart Rate and 
Mean Arterial Pressure after extubation compared to the pre extubation values.
COMPARISON OF INTRAOPERATIVE EVENTS
S.No Event  Incidence in Group 
M
Incidence  in  Group 
C
1 Hypertensive episodes                2               10
2 Additional Fentanyl requirements               2               10
3 Increased MAC requirements                0                 5
4 Hypotensive episodes                1                 2
55
5 Fluid Bolus requirement                1                 2
6 Vasopressor requirement                0                 0
7 Bradycardia                2                 2
8 ECG Changes    2(Sinus 
Bradycardia)
  2(sinus 
Bradycardia)
9 Bronchospasm                0                 0
Post Operative Events
S.No Event  Incidence in Group 
M
Incidence  in  Group 
C
 1 Bradycardia                0                 0
 2 ECG Changes                0                 0   
 3 Bronchospasm                0                 0
 4 Postoperative  Nausea  and 
vomiting
              3                  4
Comparison of Perioperative events
PONV= Post Operative Nausea and Vomiting
DISCUSSION
 Stress response due to sympathetic stimulation during laryngoscopy and 
tracheal intubation produces,
Hypertension
Tachycardia and
Tachyarrhythmias
These reflexes can be decreased by pretreatment with lignocaine intravenous 
or topical, narcotics or ß blockers,  ensuring adequate depth of anesthesia at the 
time of laryngoscopy and short duration of laryngoscopy.
Haemodynamic  repercussions of Pneumoperitoneum are
Elevations of arterial pressure
Increase in Heart rate
Increase of systemic and pulmonary vascular resistance
Decreased cardiac output
Decrease in cardiac output is due to decrease in venous return with increase 
in  intra  abdominal  pressure.   This  can  be  attenuated  by  increasing  circulatory 
volume before pneumoperitoneum by fluid loading or tilting the table to a slight 
head down position before pneumoperitoneum.
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 Increase  in  Systemic  Vascular  Resistance(SVR),  Blood  Pressure,  Heart 
Rate(HR) is considered to be mediated by mechanical  as well  as neurohumeral 
factors41.  Mechanical stimulation of peritoneal receptors also result in increased 
vasopressin  release21.   Release  of  catecholamines  and  activation  of  rennin 
angiotensin system during pneumoperitoneum  produce the hemodynamic changes 
associated  with  pneumoperitoneum8,42.Absorbed  carbon  dioxide  leading  to 
hypercarbia will produce sympathetic stimulation and increase in heart rate and 
blood pressure.
Metoprolol, a selective ß1 adrenergic blocking agent acts by 
Competitive antagonism of catecholamines at peripheral(especially cardiac) 
adrenergic neuron sites; 
A central effect leading to reduced sympathetic outflow to the periphery;
Suppression of rennin activity.
These properties of metoprolol make it a candidate for suppressing the stress 
response.   Moreover,  the  elimination  halftime  of  Metoprolol  being  3.5  hours 
allows it to be administered as a single dose covering the duration of surgery. Thus 
in  this  study  we  have  evaluated  the  efficacy  of  injection  metoprolol  50 
micrograms/kg. i.v., in attenuating these stress responses.
We  hypothesized  that  inj.Metoprolol  50mic.gms/kg.i.v.  given  5  minutes 
before  induction  of  anesthesia  will  attenuate  these  stress  responses  during 
laparoscopic  surgeries  and  it  may  cause  bradycardia,  Atrio  Ventricular 
dissociation, congestive cardiac failure, bronchospasm and nausea and vomiting. 
With the observations made we tested this hypothesis statistically and compared 
the results with a control group where metoprolol is not given.
DEMOGRAPHIC PROFILE
Both Metoprolol group(group M) and control group(group C) were similar 
in respect to age, sex and weight distribution.
There was no significant difference in duration of laryngoscopy and duration 
of pneumoperitoneum between the two groups.
HEMODYNAMIC RESPONSE TO INTUBATION
There was no significant difference in heart rate at 1 and 5 minutes after 
intubation compared to basal heart rate in both the groups.  It may be that, our 
anesthetic  technique  and  short  duration  of  laryngoscopy  effectively  prevented 
increase in heart rate.  However there was significant  increase in Mean Arterial 
Pressure(MAP), at 1 and 5 minutes after intubation compared to basal MAP in 
control group. But in Metoprolol group compared to the basal MAP at 1 minute 
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after intubation there was a small but significant decrease in MAP,5 minutes 
after  intubation  there  was  no  significant  difference  in  MAP.   From  these 
observations Metoprolol seems to be effective in attenuating the stress response to 
intubation.
These observations are similar to the findings of  Kumar M;Tikkle AC et 
al17,  who studied the effect  of inj.Metoprolol,i.v.3mgm. given 5 minutes before 
induction  of  anesthesia  and  concluded  Metoprolol  effectively  attenuated  the 
cardiovascular response to laryngoscopy and intubation
These  observations  also  correlate  with  the  study  of 
J.Manusson,M.D.,T.Thulin,O.Werner et al of sweden22, who studies the effect 
of  pretreatment  with  Metoprolol  in  patients  undergoing surgery  and  concluded 
metoprolol  significantly  reduced  arterial  pressure  both  during  undisturbed 
anesthesia and during intubation and extubation. 
Results of this study indicate Metoprolol’s efficacy in attenuating the stress 
response to intubation is comparable to Nitroglycerin , demonstrated by Mikawa 
K, Hasegawa M, Suzuki T, Obara H et al29..
Results of this study regarding the efficacy of Metoprolol in attenuating the 
stress response to intubation , is comparable to that of propronolol demonstrated by 
Maharajan  et al23.Metoprolol’s  efficacy  is  also  comparable  with  esmolol’s 
efficacy demonstrated byArthi Rathore,Dr.H.K.Guptha et al14.  
 Hemodynamic response during co2 pneumoperitoneum
There was a significant increase in Heart Rate and Mean Arterial pressure in 
Control group 15 minutes after pneumoperitoneum compared to both basal and pre 
pneumoperitoneum  values.  But  in  Metoprolol  group  there  was  no  significant 
difference in Heart Rate and Mean Arterial Pressure compared to basal and pre 
pneumoperitoneum  values.   From  the  observations  it  seems,  Metoprolol  is 
effective in attenuating the stress response induced by pneumoperitoneum.
In  attenuating  the  stress  response  to  pneumoperitoneum  results  with 
metoprolol  in this study are comparable with 
1. Propronolol,  Maharajan  SK  et  al23,,who  demonstrated 
propranolol is effective in decreasing the stress response due 
to  airway  manipulation  and  CO2 pneumoperitoneum  in 
patients undergoing laparoscopic surgeries.
2. Esmolol, Koivusalo  AM,Schejnin  M,  Tikkannen  I  et  al16 
who demonstrated that esmolol blunts the pressor response 
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to  induction  and  maintenance  of  pneumoperitoneum  and 
may protect against renal ischemia.
3.
3
4. Clonidine,JL  Jnis,JD  Chiche  et  al12,  who  found  that 
clonidine is  effective  in  attenuating the stress  response  to 
pneumoperitoneum.
  Lamintaustra R, Syvalathi E et al19, studied the effect of ß blockers on 
plasma  rennin  activity,  in  an  exercise  test  and  demonstrated  exercise  induced 
increase in plasma rennin activity can be inhibited by ß1 adrenergic blockers.
In  this  study,  1  hour  after  induction  of  anesthesia,  there  was 
significantly  more  urine  output  in  Metoprolol  group  compared  to  the  Control 
group.  Suppression of increase in rennin activity induced by pneumoperitoneum 
by Metoprolol is the likely mechanism for this observation.  This also corelates 
with the observations of , Koivusalo AM,Schejnin M, Tikkannen I et al16 , who 
demonstrated  that  esmolol  blunts  the  pressor  response  to  induction  and 
maintenance of pneumoperitoneum and may protect against renal ischemia.
RESPONSE TO EXTUBATION
In the Metoprolol group there was no significant difference in Heart 
rate  and  Mean  Arterial  Pressure  measured  before  and  after  extubation.  But  in 
Control group, there was a significant increase in both HR and MAP compared to 
the  pre  extubation  values.   Our  observations  also  correlate  with  the  study  of 
J.Manusson,M.D.,T.Thulin,O.Werner et al of sweden22..   The results are also 
comparable to that of propronolol in the study of Maharajan SK et al23.
PERIOPERATIVE EVENTS
All  the  patients  were  monitored  intraoperatively  and  8  hours  post 
operatively for any complications, and the following observations made.
Intraoperative:
S.No Event  Incidence in Group 
M
Incidence  in  Group 
C
1 Hypertensive episodes                2               10
2 Additional Fentanyl requirements               2               10
3 Increased MAC requirements                0                 5
4 Hypotensive episodes                1                 2
5 Fluid Bolus requirement                1                 2
6 Vasopressor requirement                0                 0
7 Bradycardia                2                 2
8 ECG Changes    2(Sinus 
Bradycardia)
  2(sinus 
Bradycardia)
9 Bronchospasm                0                 0
Hypertensive Episodes:
Highest  Mean Arterial  Pressure  observed in  Metoprolol  group was 
126mm of Hg,in Control group it was 134 mm of Hg. Both occurred during the 
first 15 minutes of CO2 pneumoperitoneum.
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In Metoprolol group 2 patients developed hypertensive episodes, they were 
managed with supplementing additional fentanyl. In control group 10 patients had 
hypertensive episodes, all of them were given additional fentanyl; Five among 
them required increase in Isoflurane concentration to control blood pressure. 
It  is  clear  that  opioid  requirement  and  Isoflurane  requirement  are  more  in  the 
Control group compared to the Metoprolol group.
Hypotensive Episodes:
One patient  in Metoprolol  group and two patients  in control  group 
developed hypotensive episodes. Lowest Mean arterial pressure was 62 mm of Hg. 
In Metoprolol group and 65 mm of Hg. In Control group. All of them responded to 
fluid bolus and none of them required any vasopressor.
Others:
2 patients in each group developed sinus bradycardia. Only one patient 
in the Metoprolol group developed a heart rate less than fifty(47), it  responded 
promptly to inj. Atropine 0.6mg i.v..  Other three patients who developed brady 
cardia had heart rates between 50 and 60, not associated with any hypotension and 
they did not require any treatment.  There were no other ECG abnormalities or 
bronchospasm in any of the patients in both the groups.
  
Post Operative Events
S.No Event  Incidence in Group 
M
Incidence  in  Group 
C
 1 Bradycardia                0                 0
 2 ECG Changes                0                 0   
 3 Bronchospasm                0                 0
 4 Postoperative  Nausea  and 
vomiting
              3                  4
There were no significant complications during the 8 hours post operatively 
in both group of patients, other than post operative nausea and vomiting.  Three 
patients  in the Metoprolol group and four patients in the Control group had post 
operative nausea and vomiting,  all  of  them occurred during the first  hour  post 
operatively. There was no significant difference in the average hourly urine output 
between the two groups.
In  this  study  there  was  no  significant  difference  in  the  incidence  of 
complications between the Metoprolol group and the Control group.
65
 SUMMARY
Aim  of  this  study  is  to  evaluate  the  efficacy  of  inj.Metoprolol  50 
mic.gms/kg. i.v. given 5 minutes before induction of anesthesia in attenuating the 
hemodynamic response to intubation and carbon dioxide pneumoperitoneum and to 
look for any adverse effects.
There  was  no  significant  difference  between  the  Metoprolol  group  and 
Control group in respect to age, sex distribution, weight, Airway class, duration of 
laryngoscopy and pneumoperitoneum.
After 1 and 5 minutes after intubation, there was no significant increase in 
heart rate compared to basal heart rate in both the group.  Our anesthetic technique 
was sufficient to blunt the heart rate response to intubation in the control group. 
But there was significant increase in Mean Arterial Pressure in Control group from 
basal readings during both 1 and 5 minutes after intubation. In Metoprolol group 
there was a small but significant decrease in Mean Arterial Pressure 1 minute after 
intubation, and no significant change 5 minutes after intubation.
 During CO2 Pneumoperitoneum there was a  significant  increase in Heart 
Rate  and  Mean  Arterial  pressure  in  Control  group  15  minutes  after 
pneumoperitoneum compared to both basal and pre pneumoperitoneum values. But 
in Metoprolol group there was no significant difference in Heart Rate and Mean 
Arterial Pressure compared to basal and pre pneumoperitoneum values. There was 
no significant difference in Heart Rate and Mean Arterial Pressure recordings at 
15,30,45 minutes after pneumoperitoneum in both the groups.
Similarly, there was a significant increase in Heart Rate and Mean Arterial 
Pressure  in  Control  group  after  extubation  compared  to  the  pre  extubation 
readings.  But there was no significant difference in Heart Rate and Mean Arterial 
Pressure  between  pre  extubation  and after  extubation  recordings  in  Metoprolol 
group.   Moreover,  there  was  significantly  more  urine  output  after  1  hour  of 
induction of anesthesia in Metoprolol group compared to Control group.
In Metoprolol group two patients had hypertensive episodes and they were 
controlled with additional fentanyl supplementation.  In Control group ten patients 
developed hypertensive episodes all of them were given additional fentanyl.  In 
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addition to fentanyl 5 of them required additional increase in Isoflurane inspired 
concentrations to control the increase in blood pressure. One patient in the 
Metoprolol group and two in the Control group had hypotensive episodes, 
and they were managed with fluid boluses.   None required vasopressors.   Two 
patients in both the groups developed sinus bradycardia, Three of them did not 
require any treatment, one in the Metoprolol group was treated with inj. Atropine 
0.6mg i.v. Three patients in Metoprolol group and four patients in Control group 
had mild postoperative nausea and vomiting. 
Many studies have demonstrated similar efficacy with other ß blockers like 
propranolol  and  esmolol,Metoprolol  scores  over  propranolol  in  being 
cardioselective so  that  it  can  be used  in  situations where propranolol  is  contra 
indicated.  The disadvantage with esmolol is, it has to be repeated or an infusion 
has to be maintained because of its ultra short duration of action, whereas a single 
dose of Metoprolol is effective for the entire duration of surgery.  
 CONCLUSION
1. Inj.Metoprolol 5µgm./kg. i.v. given 5 minutes before induction of 
anesthesia  effectively  attenuates  the  hemodynamic  response  to 
laryngoscopy, intubation and carbon dioxide pneumoperitoneum
2. There  were  no  significant  complications  associated  with 
inj.Metoprolol  50µgm./kg/i.v  during  intraoperative  period  and  8 
hours postoperatively.
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PROFORMA
Name :
Age : Sex: Weight:
Serial No:
ASA Status:                                 Airway: MPC
Time Heart Rate BP 
Systolic/diastoli
c(MAP)
ETCO2 SpO2
Basal
1  minute  after 
intubation
5  minutes  after 
intubation
Before 
pneumoperitone
um(PNP)
15 minutes after 
PNP
30  min  after 
PNP
45  min  after 
PNP
Before 
extubation
After extubation
Duration of laryngoscopy :
:
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Duration of surgery :
Episodes of Hypertension :
Timing :
Managed with :
Episodes of Hypotension :
Timing :
Managed with :
Other complications :
Hourly urine output :
Bradycardia: lowest HR: Managed with( total dose required)
ECG changes:
Bronchospasm;           
Any other com plications:
Intraoperatively:
Postoperatively
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